TNNI3 and acute coronary syndrome: cTNI has been widely studied as a diagnostic and prognostic marker of the acute coronary syndrome (ACS), and a previous study has reported that patients with ACS with anti-cTNI autoantibodies will eventually trigger severe autoimmune inflammation if mistaken by the immune system for antigens rather than self-protein (30).